FDA Open To Home COVID-19 Testing With Caveats, OIVD’s Stenzel Says
Executive Summary
The US FDA is open to the idea of home-testing for the COVID-19 virus, but only after making sure the test is completely safe and effective, and available only through a physician’s oversight, said Tim Stenzel, director of the agency’s Office of In Vitro Diagnostics and Radiological Health.
You may also be interested in...
COVID-19: FDA Anticipates Further Serology Test Development
US FDA staff discussed hopes for additional serology and saliva tests for COVID-19, as well as at-home test options, during a 15 April webinar.
3D-Printed Swab Partnership Plans 1M Weekly, Including Bulk Packages Available To Consumers
Resolution Medical teamed with Carbon to make more than 1m 3D-printed nasal swabs a week to address the shortage for COVID-19 testing. It will offer the swabs online in boxes of 1,000 to US consumers.
Becton Dickinson, BioMedomics Collaborate On Rapid Serology COVID-19 Test
BD and BioMedomics will soon begin distributing a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.